Conley, Shannon M.

RPE65: Role in the Visual Cycle, Human Retinal Disease, and Gene Therapy

Cai, X., Conley, S. M., & Naash, M. I. (2009) · Ophthalmic Genetics

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 162

DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice

Han, Z., Conley, S. M., Makkia, R. S., Cooper, M. J., & Naash, M. I. (2012) · Journal of Clinical Investigation

Retinal Development and DisordersRNA Interference and Gene Delivery

Cited by 150

A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA Nanoparticles

Cai, X., Nash, Z., Conley, S. M., Fliesler, S. J., Cooper, M. J., & Naash, M. I. (2009) · PLoS ONE

Retinal Development and DisordersRNA Interference and Gene Delivery

Cited by 109

S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA

Koirala, A., Makkia, R. S., Conley, S. M., Cooper, M. J., & Naash, M. I. (2013) · Human Molecular Genetics

RNA Interference and Gene DeliveryRetinal Development and Disorders

Cited by 75

Gene therapy for Stargardt disease associated with ABCA4 gene

Han, Z., Conley, S. M., & Naash, M. I. (2014) · Advances in Experimental Medicine and Biology

Retinal Development and DisordersVirus-based gene therapy research

Cited by 74

Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype

Han, Z., Banworth, M. J., Makkia, R., Conley, S. M., Al‐Ubaidi, M. R., Cooper, M. J., & Naash, M. I. (2015) · The FASEB Journal

Retinal Development and DisordersRNA Interference and Gene Delivery

Cited by 54

Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy

Conley, S. M., Cai, X., Makkia, R., Wu, Y., Sparrow, J. R., & Naash, M. I. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 54

Non-viral therapeutic approaches to ocular diseases: An overview and future directions

Zulliger, R., Conley, S. M., & Naash, M. I. (2015) · Journal of Controlled Release

RNA Interference and Gene DeliveryAdvanced Drug Delivery Systems

Cited by 50

Persistence of non-viral vector mediated RPE65 expression: Case for viability as a gene transfer therapy for RPE-based diseases

Koirala, A., Conley, S. M., Makkia, R., Liu, Z., Cooper, M. J., Sparrow, J. R., & Naash, M. I. (2013) · Journal of Controlled Release

Retinal Development and DisordersRNA Interference and Gene Delivery

Cited by 47